WoodTrust Financial Corp Buys 9,000 Shares of Neogen Co. (NASDAQ:NEOG)

WoodTrust Financial Corp lifted its stake in Neogen Co. (NASDAQ:NEOG) by 19.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 55,925 shares of the company’s stock after buying an additional 9,000 shares during the quarter. WoodTrust Financial Corp’s holdings in Neogen were worth $940,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. William Blair Investment Management LLC lifted its holdings in Neogen by 64.7% during the second quarter. William Blair Investment Management LLC now owns 12,013,072 shares of the company’s stock valued at $187,764,000 after purchasing an additional 4,717,696 shares in the last quarter. Select Equity Group L.P. raised its position in shares of Neogen by 23.1% during the 2nd quarter. Select Equity Group L.P. now owns 15,530,439 shares of the company’s stock valued at $242,741,000 after purchasing an additional 2,914,893 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Neogen by 148.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,109,180 shares of the company’s stock worth $64,229,000 after buying an additional 2,454,566 shares during the period. Shapiro Capital Management LLC purchased a new stake in Neogen in the 2nd quarter worth $31,087,000. Finally, Fred Alger Management LLC raised its holdings in Neogen by 542.3% during the second quarter. Fred Alger Management LLC now owns 2,137,317 shares of the company’s stock valued at $33,406,000 after acquiring an additional 1,804,550 shares during the period. 96.73% of the stock is owned by hedge funds and other institutional investors.

Neogen Stock Performance

NEOG opened at $15.62 on Thursday. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of -142.00 and a beta of 1.23. Neogen Co. has a fifty-two week low of $11.46 and a fifty-two week high of $20.89. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.79 and a current ratio of 4.41. The company has a fifty day moving average of $15.43 and a 200 day moving average of $15.29.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Thursday, October 10th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). The firm had revenue of $217.00 million for the quarter, compared to analysts’ expectations of $215.05 million. Neogen had a negative net margin of 2.58% and a positive return on equity of 2.80%. The company’s revenue for the quarter was down 5.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.11 EPS. As a group, sell-side analysts forecast that Neogen Co. will post 0.52 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on NEOG shares. StockNews.com raised Neogen to a “sell” rating in a research note on Monday, September 30th. Piper Sandler upped their price target on Neogen from $17.00 to $17.50 and gave the stock a “neutral” rating in a research note on Tuesday, August 6th.

Insider Buying and Selling at Neogen

In other news, CEO John Edward Adent bought 14,500 shares of the stock in a transaction dated Friday, October 11th. The stock was purchased at an average cost of $13.80 per share, for a total transaction of $200,100.00. Following the transaction, the chief executive officer now owns 216,477 shares of the company’s stock, valued at $2,987,382.60. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.13% of the stock is currently owned by company insiders.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.